SFU
AMAG

Stonehage Fleming (UK)’s AMAG Pharmaceuticals AMAG Stock Holding History

Stonehage Fleming (UK)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-882
Closed -$38K – 280
2014
Q4 		$38K Buy
+882
New +$31.9K 0.02% 185

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stonehage Fleming (UK)'s AMAG Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of AMAG Pharmaceuticals (AMAG) in Q1 2015, closing a stake of 882 shares — an estimated $38K sold.

Stonehage Fleming (UK) first reported a position in AMAG in Q4 2014 and held it in 1 quarter. The position peaked at $38K in Q4 2014. 197 funds tracked by Wall St. Rank hold AMAG as of Q1 2015.

  • Stonehage Fleming (UK) reported no remaining AMAG Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 882 AMAG Pharmaceuticals shares in Q1 2015, an estimated $38K.
  • Stonehage Fleming (UK) first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Stonehage Fleming (UK)'s AMAG Pharmaceuticals position peaked at $38K in Q4 2014.
  • 197 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.